Elizabeth J Malcolm, MD
Internal Medicine · Durham
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 30 years
- New York Medical College, 1996
Offices
3 locations · Legacy Healthcare Services Inc · Duke Health Integrated Practice Inc · Duke University Affiliated Physicians, Inc.
Hospitals listed: 347136 · Duke Regional Hospital · Duke University Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Malcolm’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A63902 · Cancelled
Licence status: Cancelled · since 1997 · New York Medical College.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Duke Regional HospitalDurham, NCAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Duke University Health System, which runs 3 hospitalsPatients rate it 4 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.245, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.204, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0, Oct 2024 – Sep 2025
- Duke University HospitalDurham, NCAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Duke University Health System, which runs 3 hospitalsHome of Duke Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 216.01 (186.77 to 245.25) · 366 cases, Jul 2022 – Jun 2024Worse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.5 (4.26 to 6.75) · 6,581 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative acute kidney injury requiring dialysis rate: 2.95 (2.11 to 3.79) · 3,680 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.374, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.727, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.398, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.592, Oct 2024 – Sep 2025Better than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 8.6 (7.5 to 9.8) · 2,101 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Duke Regional Hospital
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.245 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.204 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.12 (0.12 to 2.12) · 931 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.65 to 1.31) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 134.57 (80.4 to 188.74) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 138 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.5 · 109 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.7 · 363 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 327 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.5 · 239 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.5 · 3,382 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.01 to 0.44) · 5,561 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.06 to 0.45) · 5,533 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.2 (2.09 to 6.31) · 1,215 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.91 (0.28 to 3.55) · 472 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.62 (1.09 to 4.16) · 1,088 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.07 (1.89 to 16.25) · 503 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.64 (0.88 to 8.4) · 468 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.16) · 234 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0 to 1.18) · 4,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 96 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.566 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.305 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.4 · 165 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.3 · 792 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 7.2 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -14.5 · 400 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -15.4 · 348 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 578 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.3 to 7.5) · 80 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.3 (8.8 to 16.6) · 80 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.5 · 98 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.6 · 283 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.2 (8.7 to 14.8) · 1,346 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 504 cases | No different | Jan 2024 – Dec 2024 |
What patients said (604 patients answered, 19% of those asked)
| Cleanliness | 2 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 59% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 84% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 79% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Duke University Hospital
Behind the star rating — Deaths: 4 better, 3 the same, 1 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 216.01 (186.77 to 245.25) · 366 cases | Worse | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.5 (4.26 to 6.75) · 6,581 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.95 (2.11 to 3.79) · 3,680 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.374 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.727 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.398 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.592 | Better | Oct 2024 – Sep 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 8.6 (7.5 to 9.8) · 2,101 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.91 (0.21 to 1.61) · 4,083 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.1 (0.94 to 1.26) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.6 · 277 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 175 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.4 · 351 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.6 · 530 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.4 · 684 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.3 · 10,510 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.32) · 15,279 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.04 to 0.36) · 16,992 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.62 (1.69 to 3.56) · 5,880 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.88 (6.29 to 11.47) · 3,482 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (4.07 to 7.84) · 3,644 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.49 (1.26 to 3.72) · 1,495 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.5 (0.15 to 0.85) · 14,819 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.9 · 293 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 1.373 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.048 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 688 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 1,551 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 7.3 · 428 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -20.2 · 963 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.2 · 554 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.9 · 861 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (4.1 to 5.8) · 2,101 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.9 · 320 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.7 · 312 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 367 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.2 to 16) · 2,489 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1) · 2,623 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,341 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 82% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$22,013
Medicare paid this office $22,013 for 137 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 115 | $14,323 | $62 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 47 | $5,584 | $119 |
Who their Medicare patients are
137 Original Medicare patients in 2024. Average age 72 · Women 66% · Also on Medicaid 20% · Health risk score 1.19. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Chronic kidney disease 26% · Depression 26% · Diabetes 23% · Coronary heart disease 20% · Heart failure 18% · Cancer 18% · Atrial fibrillation 12% · COPD 11% · Stroke 9%.
The office billed $83,205, Medicare allowed $29,275 and paid $22,013; for 330 services of 19 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 137 | 330 | 72 | 1.19 | $83,205 | $22,013 |
| 2023 | 134 | 466 | 72 | 1.10 | $98,157 | $29,386 |
| 2022 | 157 | 1,024 | 73 | 0.91 | $155,477 | $47,629 |
| 2021 | 132 | 847 | 73 | 1.01 | $133,980 | $40,381 |
| 2020 | 153 | 884 | 73 | 1.11 | $109,846 | $32,990 |
| 2019 | 101 | 489 | 70 | 1.22 | $73,867 | $19,666 |
| 2018 | 122 | 186 | 74 | 1.30 | $30,081 | $7,834 |
| 2017 | 138 | 145 | 74 | 1.19 | $27,385 | $9,015 |
| 2016 | 69 | 72 | 75 | 1.71 | $15,358 | $5,290 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Return visit (30+ min) | 108 | $15,498 | $75 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 65 | $7,938 | $122 |
| Short return visit (20+ min) | 29 | $1,555 | $46 |
| Insertion of needle into vein for collection of blood sample | 71 | $857 | $8 |
2022: 16 services
| Return visit (30+ min) | 92 | $19,406 | $90 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 61 | $7,665 | $126 |
| Short return visit (20+ min) | 81 | $6,418 | $61 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 15 | $3,766 | $251 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 28 | $1,967 | $70 |
| Long return visit (40+ min) | 12 | $1,482 | $99 |
| Short return visit | 18 | $860 | $41 |
| Insertion of needle into vein for collection of blood sample | 118 | $821 | $3 |
| Administration of influenza virus vaccine | 29 | $813 | $28 |
| Administration of pneumococcal vaccine | 22 | $622 | $28 |
| Adm sarscv2 bvl 30mcg/.3ml a | 12 | $445 | $37 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 47 | $417 | $7 |
| Hemoglobin a1c level | 18 | $307 | $10 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 30 | $197 | $6 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 11 | $54 | $5 |
| Automated urinalysis test | 16 | $38 | $2 |
2021: 12 services
| Return visit (30+ min) | 96 | $16,643 | $88 |
| Short return visit (20+ min) | 58 | $5,668 | $62 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 43 | $5,519 | $128 |
| Pneumococcal vaccine, 23-valent | 18 | $2,070 | $115 |
| Influenza vaccine split virus, preservative free | 30 | $1,958 | $65 |
| Long return visit (40+ min) | 11 | $1,312 | $119 |
| New patient visit (45+ min) | 13 | $999 | $77 |
| Insertion of needle into vein for collection of blood sample | 102 | $636 | $3 |
| Administration of influenza virus vaccine | 31 | $504 | $16 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 57 | $486 | $8 |
| Administration of pneumococcal vaccine | 27 | $438 | $16 |
| Hemoglobin a1c level | 22 | $340 | $10 |
2020: 12 services
| Return visit (30+ min) | 69 | $7,449 | $77 |
| Short return visit (20+ min) | 96 | $6,306 | $47 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 34 | $3,858 | $113 |
| Telephone medical discussion with physician, 11-20 minutes | 48 | $3,093 | $52 |
| Influenza vaccine split virus, preservative free | 49 | $2,958 | $60 |
| Pneumococcal vaccine, 23-valent | 14 | $1,607 | $115 |
| Administration of influenza virus vaccine | 53 | $854 | $16 |
| Insertion of needle into vein for collection of blood sample | 115 | $605 | $3 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 54 | $470 | $8 |
| Administration of pneumococcal vaccine | 22 | $353 | $16 |
| Hemoglobin a1c level | 25 | $329 | $10 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 14 | $97 | $6 |
2019: 11 services
| Return visit (30+ min) | 47 | $5,103 | $77 |
| Short return visit (20+ min) | 55 | $4,832 | $52 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 24 | $2,695 | $112 |
| Influenza vaccine split virus, preservative free | 23 | $1,254 | $55 |
| Administration of influenza virus vaccine | 25 | $411 | $16 |
| Insertion of needle into vein for collection of blood sample | 53 | $282 | $3 |
| Hemoglobin a1c level | 17 | $254 | $11 |
| Short return visit | 12 | $207 | $16 |
| Administration of pneumococcal vaccine | 11 | $174 | $16 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 16 | $152 | $8 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 12 | $92 | $7 |
2018: 4 services
| Return visit (30+ min) | 44 | $2,935 | $65 |
| Short return visit (20+ min) | 45 | $2,217 | $49 |
| Short return visit | 17 | $430 | $24 |
| Insertion of needle into vein for collection of blood sample | 12 | $38 | $3 |
2017: 3 services
| Return visit (30+ min) | 68 | $5,053 | $73 |
| Short return visit (20+ min) | 39 | $1,693 | $43 |
| New patient visit (30+ min) | 12 | $882 | $73 |
2016: 3 services
| Return visit (30+ min) | 25 | $1,996 | $80 |
| Long return visit (40+ min) | 12 | $1,367 | $114 |
| Short return visit (20+ min) | 22 | $1,003 | $44 |
Medicaid work
$14,200 in 2024
Medicaid paid $14,200 for 523 billed services this clinician did in 2024, up to 36 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit | 234 | $7,743 |
| Return visit (30+ min) | 172 | $6,125 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 103 | $221 |
| Hemoglobin A1C level | 14 | $111 |
| 2024 | 523 | 4 | 36 | $14,200 |
| 2023 | 136 | 2 | 24 | $3,251 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 89 | $2,271 |
| Short return visit | 47 | $980 |
Drugs they prescribed that Part D paid
$289,505
Pharmacies billed $289,505 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (40 of 2,757) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
2,365 generic and fewer than 11 brand-name prescriptions · $289,505 in drug cost · 46 antibiotic prescriptions to 27 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 75 | $76,516 | $1,020 |
| Eliquis | 41 | $37,158 | $906 |
| Jardiance | 40 | $35,049 | $876 |
| Trelegy Ellipta | 25 | $20,755 | $830 |
| Trulicity | 11 | $13,639 | $1,240 |
See all 64 drugs
| Ozempic | 75 | $76,516 | $1,020 |
| Eliquis | 41 | $37,158 | $906 |
| Jardiance | 40 | $35,049 | $876 |
| Trelegy Ellipta | 25 | $20,755 | $830 |
| Trulicity | 11 | $13,639 | $1,240 |
| Januvia | 15 | $10,714 | $714 |
| Breo Ellipta | 21 | $8,564 | $408 |
| Risedronate | 15 | $2,593 | $173 |
| Atorvastatin | 248 | $1,863 | $8 |
| Diltiazem 24hr Er (Cd) | 11 | $1,053 | $96 |
| Allopurinol | 17 | $953 | $56 |
| Pregabalin | 13 | $932 | $72 |
| Losartan | 111 | $917 | $8 |
| Telmisartan | 32 | $913 | $29 |
| Levothyroxine | 85 | $903 | $11 |
| Fluticasone Propionate | 54 | $818 | $15 |
| Omeprazole | 46 | $779 | $17 |
| Rosuvastatin | 59 | $712 | $12 |
| Wixela Inhub | 12 | $710 | $59 |
| Bupropion Xl | 47 | $685 | $15 |
| Metformin Hcl Er | 60 | $675 | $11 |
| Albuterol Sulfate Hfa | 24 | $665 | $28 |
| Gabapentin | 63 | $652 | $10 |
| Oxycodone-Acetaminophen | 21 | $650 | $31 |
| Ezetimibe | 16 | $615 | $38 |
| Amlodipine Besylate | 124 | $605 | $5 |
| Potassium Chloride | 23 | $586 | $25 |
| Lacosamide | 15 | $533 | $36 |
| Ipratropium | 19 | $512 | $27 |
| Pantoprazole | 73 | $511 | $7 |
| Duloxetine | 36 | $483 | $13 |
| Tamsulosin | 39 | $464 | $12 |
| Sertraline | 65 | $450 | $7 |
| Valacyclovir | 13 | $441 | $34 |
| Mirtazapine | 30 | $439 | $15 |
| Trazodone | 52 | $433 | $8 |
| Spironolactone | 47 | $419 | $9 |
| Carvedilol | 68 | $395 | $6 |
| Metformin | 57 | $393 | $7 |
| Lisinopril | 47 | $338 | $7 |
| Diclofenac | 14 | $309 | $22 |
| Metoprolol | 20 | $278 | $14 |
| Famotidine | 13 | $265 | $20 |
| Spironolactone-Hctz | 12 | $235 | $20 |
| Escitalopram | 22 | $234 | $11 |
| Finasteride | 28 | $226 | $8 |
| Amitriptyline | 17 | $214 | $13 |
| Dextroamphetamine Sulfate Er | 12 | $193 | $16 |
| Pravastatin | 11 | $162 | $15 |
| Olmesartan Medoxomil | 13 | $130 | $10 |
| Ondansetron Odt | 13 | $110 | $8 |
| Triamterene-Hydrochlorothiazid | 11 | $95 | $9 |
| Meclizine | 11 | $84 | $8 |
| Citalopram Hbr | 14 | $67 | $5 |
| Furosemide | 18 | $63 | $4 |
| Metoprolol | 17 | $60 | $4 |
| Alendronate | 15 | $55 | $4 |
| Fluoxetine | 15 | $54 | $4 |
| Venlafaxine Hcl Er | 11 | $46 | $4 |
| Hydrochlorothiazide | 24 | $42 | $2 |
| Prednisone | 16 | $33 | $2 |
| Clonidine | 14 | $28 | $2 |
| Meloxicam | 20 | $13 | $1 |
| Paxlovid | 11 | $0 | $0 |
Year by year
| 2024 | 2,757 | 231 | 2% (40) | None | $289,505 |
| 2023 | 2,684 | 200 | 1% (31) | 13% | $297,646 |
| 2022 | 2,883 | 191 | 2% (43) | 13% | $284,318 |
| 2021 | 2,713 | 216 | 1% (37) | 15% | $269,516 |
| 2020 | 2,503 | 230 | 2% (57) | 15% | $205,555 |
| 2019 | 886 | 127 | 2% (19) | 13% | $59,520 |
| 2018 | 113 | 69 | 0% (0) | 22% | $5,372 |
| 2017 | 95 | 63 | None | 20% | $7,022 |
| 2016 | 51 | 34 | None | None | $1,367 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 63 drugs
| Ozempic | 54 | $54,854 | $1,016 |
| Eliquis | 23 | $23,906 | $1,039 |
| Trulicity | 14 | $20,746 | $1,482 |
| Jardiance | 19 | $18,169 | $956 |
| Januvia | 15 | $16,663 | $1,111 |
| Breo Ellipta | 35 | $15,422 | $441 |
| Xarelto | 12 | $12,272 | $1,023 |
| Atorvastatin | 273 | $3,086 | $11 |
| Fosfomycin Tromethamine | 12 | $2,985 | $249 |
| Diltiazem 24hr Er (Cd) | 22 | $1,992 | $91 |
| Potassium Chloride | 17 | $1,498 | $88 |
| Losartan | 112 | $1,333 | $12 |
| Pantoprazole | 63 | $1,292 | $21 |
| Levothyroxine | 81 | $1,251 | $15 |
| Amlodipine Besylate | 134 | $1,209 | $9 |
| Gabapentin | 53 | $1,004 | $19 |
| Dextroamphetamine Sulfate Er | 11 | $992 | $90 |
| Fluticasone Propionate | 28 | $880 | $31 |
| Valacyclovir | 18 | $754 | $42 |
| Bupropion Xl | 44 | $746 | $17 |
| Duloxetine | 44 | $694 | $16 |
| Metformin | 46 | $688 | $15 |
| Oxycodone-Acetaminophen | 21 | $685 | $33 |
| Carvedilol | 55 | $668 | $12 |
| Rosuvastatin | 66 | $667 | $10 |
| Telmisartan | 27 | $620 | $23 |
| Metformin Hcl Er | 46 | $604 | $13 |
| Tamsulosin | 38 | $602 | $16 |
| Ezetimibe | 13 | $554 | $43 |
| Escitalopram | 39 | $553 | $14 |
| Omeprazole | 51 | $551 | $11 |
| Diclofenac | 19 | $536 | $28 |
| Lisinopril | 50 | $509 | $10 |
| Spironolactone | 40 | $509 | $13 |
| Sertraline | 64 | $502 | $8 |
| Azelastine | 15 | $473 | $32 |
| Metoprolol | 19 | $367 | $19 |
| Metoprolol | 26 | $362 | $14 |
| Trazodone | 33 | $359 | $11 |
| Albuterol Sulfate Hfa | 16 | $331 | $21 |
| Venlafaxine Hcl Er | 11 | $329 | $30 |
| Lisinopril-Hydrochlorothiazide | 15 | $326 | $22 |
| Hydrochlorothiazide | 37 | $304 | $8 |
| Valsartan | 25 | $284 | $11 |
| Amitriptyline | 17 | $278 | $16 |
| Olmesartan Medoxomil | 12 | $265 | $22 |
| Verapamil Er | 14 | $259 | $18 |
| Hydralazine | 14 | $231 | $16 |
| Triamcinolone Acetonide | 11 | $202 | $18 |
| Glipizide Er | 15 | $190 | $13 |
| Finasteride | 17 | $184 | $11 |
| Ciprofloxacin | 14 | $181 | $13 |
| Meloxicam | 22 | $179 | $8 |
| Prednisone | 15 | $167 | $11 |
| Triamterene-Hydrochlorothiazid | 14 | $161 | $11 |
| Famotidine | 12 | $158 | $13 |
| Citalopram Hbr | 29 | $157 | $5 |
| Mirtazapine | 13 | $151 | $12 |
| Fluoxetine | 14 | $125 | $9 |
| Alendronate | 19 | $122 | $6 |
| Donepezil | 11 | $118 | $11 |
| Amoxicillin-Clavulanate Potass | 12 | $93 | $8 |
| Furosemide | 18 | $86 | $5 |
2022: 68 drugs
| Ozempic | 41 | $38,978 | $951 |
| Jardiance | 26 | $20,788 | $800 |
| Trulicity | 18 | $17,000 | $944 |
| Eliquis | 15 | $16,839 | $1,123 |
| Xarelto | 18 | $14,972 | $832 |
| Enoxaparin | 12 | $10,531 | $878 |
| Trelegy Ellipta | 12 | $8,161 | $680 |
| Spiriva Respimat | 13 | $6,849 | $527 |
| Tresiba Flextouch U-100 | 11 | $6,586 | $599 |
| Breo Ellipta | 12 | $5,585 | $465 |
| Vyvanse | 13 | $4,895 | $377 |
| Symbicort | 11 | $4,453 | $405 |
| Atorvastatin | 305 | $3,272 | $11 |
| Diltiazem 24hr Er (Cd) | 14 | $1,693 | $121 |
| Losartan | 145 | $1,496 | $10 |
| Levothyroxine | 77 | $1,213 | $16 |
| Dextroamphetamine Sulfate Er | 13 | $1,116 | $86 |
| Trazodone | 26 | $1,046 | $40 |
| Bupropion Xl | 37 | $1,046 | $28 |
| Amlodipine Besylate | 149 | $1,034 | $7 |
| Albuterol Sulfate Hfa | 20 | $1,018 | $51 |
| Azelastine | 20 | $912 | $46 |
| Rosuvastatin | 57 | $904 | $16 |
| Sertraline | 67 | $893 | $13 |
| Gabapentin | 77 | $866 | $11 |
| Metformin | 56 | $863 | $15 |
| Metoprolol | 45 | $831 | $18 |
| Ultra-Fine Mini Pen Needle | 13 | $756 | $58 |
| Carvedilol | 53 | $666 | $13 |
| Potassium Chloride | 24 | $666 | $28 |
| Fluticasone Propionate | 27 | $623 | $23 |
| Diclofenac | 20 | $600 | $30 |
| Valsartan | 25 | $591 | $24 |
| Pantoprazole | 53 | $589 | $11 |
| Pregabalin | 12 | $559 | $47 |
| Lisinopril | 77 | $554 | $7 |
| Valacyclovir | 15 | $550 | $37 |
| Escitalopram | 51 | $509 | $10 |
| Telmisartan | 14 | $491 | $35 |
| Omeprazole | 56 | $434 | $8 |
| Spironolactone | 30 | $421 | $14 |
| Hydrochlorothiazide | 61 | $419 | $7 |
| Lansoprazole | 11 | $406 | $37 |
| Duloxetine | 20 | $401 | $20 |
| Famotidine | 25 | $400 | $16 |
| Metformin Hcl Er | 30 | $348 | $12 |
| Glipizide Er | 36 | $330 | $9 |
| Baclofen | 16 | $314 | $20 |
| Tamsulosin | 28 | $314 | $11 |
| Tizanidine | 12 | $306 | $26 |
| Oxycodone-Acetaminophen | 25 | $285 | $11 |
| Oxybutynin Chloride Er | 15 | $274 | $18 |
| Furosemide | 36 | $222 | $6 |
| Triamterene-Hydrochlorothiazid | 22 | $216 | $10 |
| Fluoxetine | 15 | $215 | $14 |
| Amoxicillin-Clavulanate Potass | 13 | $192 | $15 |
| Venlafaxine Hcl Er | 13 | $190 | $15 |
| Bupropion Hcl Sr | 11 | $151 | $14 |
| Citalopram Hbr | 45 | $142 | $3 |
| Losartan-Hydrochlorothiazide | 15 | $129 | $9 |
| Cyclobenzaprine | 14 | $121 | $9 |
| Zolpidem | 23 | $106 | $5 |
| Pramipexole Dihydrochloride | 14 | $105 | $7 |
| Prednisone | 20 | $104 | $5 |
| Simvastatin | 12 | $72 | $6 |
| Allopurinol | 18 | $55 | $3 |
| Triamcinolone Acetonide | 12 | $54 | $5 |
| Meclizine | 11 | $52 | $5 |
2021: 72 drugs
| Eliquis | 29 | $24,832 | $856 |
| Ozempic | 26 | $22,869 | $880 |
| Xarelto | 25 | $18,619 | $745 |
| Januvia | 16 | $16,801 | $1,050 |
| Jardiance | 22 | $15,940 | $725 |
| Trulicity | 15 | $15,188 | $1,013 |
| Novolog Flexpen | 14 | $14,092 | $1,007 |
| Savella | 12 | $11,185 | $932 |
| Spiriva Respimat | 16 | $8,062 | $504 |
| Symbicort | 16 | $6,302 | $394 |
| Spiriva | 12 | $6,105 | $509 |
| Vyvanse | 12 | $4,303 | $359 |
| Diltiazem 24hr Er (Cd) | 13 | $2,962 | $228 |
| Atorvastatin | 206 | $2,428 | $12 |
| Gabapentin | 92 | $1,622 | $18 |
| Azelastine | 22 | $1,444 | $66 |
| Levothyroxine | 73 | $1,437 | $20 |
| Sertraline | 76 | $1,198 | $16 |
| Omeprazole | 75 | $1,116 | $15 |
| Bupropion Xl | 26 | $1,107 | $43 |
| Dextroamphetamine Sulfate Er | 12 | $1,040 | $87 |
| Ezetimibe | 15 | $1,003 | $67 |
| Losartan | 91 | $997 | $11 |
| Synthroid | 12 | $984 | $82 |
| Metoprolol | 56 | $941 | $17 |
| Rosuvastatin | 33 | $930 | $28 |
| Amlodipine Besylate | 135 | $911 | $7 |
| Diclofenac | 20 | $853 | $43 |
| Ultra-Fine Mini Pen Needle | 16 | $838 | $52 |
| Potassium Chloride | 31 | $672 | $22 |
| Fluticasone Propionate | 25 | $638 | $26 |
| Trazodone | 38 | $604 | $16 |
| Metformin | 66 | $586 | $9 |
| Lisinopril | 92 | $519 | $6 |
| Losartan-Hydrochlorothiazide | 24 | $516 | $22 |
| Carvedilol | 57 | $499 | $9 |
| Spironolactone | 40 | $452 | $11 |
| Hydrochlorothiazide | 66 | $394 | $6 |
| Lansoprazole | 13 | $364 | $28 |
| Valsartan | 13 | $357 | $27 |
| Pravastatin | 19 | $349 | $18 |
| Valacyclovir | 12 | $344 | $29 |
| Metformin Hcl Er | 27 | $338 | $13 |
| Pregabalin | 14 | $326 | $23 |
| Pantoprazole | 29 | $323 | $11 |
| Famotidine | 20 | $319 | $16 |
| Escitalopram | 24 | $312 | $13 |
| Venlafaxine Hcl Er | 15 | $285 | $19 |
| Oxycodone-Acetaminophen | 18 | $276 | $15 |
| Triamterene-Hydrochlorothiazid | 24 | $263 | $11 |
| Glipizide Er | 28 | $240 | $9 |
| Benazepril | 12 | $237 | $20 |
| Hydralazine | 15 | $232 | $15 |
| Lovastatin | 13 | $225 | $17 |
| Furosemide | 46 | $212 | $5 |
| Omega-3 Acid Ethyl Esters | 14 | $189 | $14 |
| Citalopram Hbr | 32 | $183 | $6 |
| Tamsulosin | 15 | $177 | $12 |
| Baclofen | 14 | $170 | $12 |
| Atenolol | 11 | $157 | $14 |
| Clopidogrel | 12 | $143 | $12 |
| Bupropion Hcl Sr | 11 | $143 | $13 |
| Pramipexole Dihydrochloride | 19 | $138 | $7 |
| Simvastatin | 11 | $122 | $11 |
| Cyclobenzaprine | 11 | $119 | $11 |
| Fluoxetine | 11 | $118 | $11 |
| Lisinopril-Hydrochlorothiazide | 18 | $112 | $6 |
| Allopurinol | 22 | $95 | $4 |
| Tramadol | 12 | $88 | $7 |
| Buspirone | 16 | $85 | $5 |
| Triamcinolone Acetonide | 14 | $84 | $6 |
| Zolpidem | 14 | $71 | $5 |
2020: 63 drugs
| Eliquis | 42 | $26,139 | $622 |
| Ozempic | 18 | $14,935 | $830 |
| Jardiance | 20 | $12,925 | $646 |
| Xarelto | 25 | $11,743 | $470 |
| Novolog Flexpen | 12 | $9,152 | $763 |
| Januvia | 15 | $8,921 | $595 |
| Spiriva | 11 | $5,114 | $465 |
| Atorvastatin | 134 | $1,737 | $13 |
| Levothyroxine | 81 | $1,670 | $21 |
| Gabapentin | 65 | $1,145 | $18 |
| Diclofenac | 40 | $1,106 | $28 |
| Metoprolol | 49 | $1,046 | $21 |
| Ventolin Hfa | 15 | $979 | $65 |
| Omeprazole | 64 | $933 | $15 |
| Trazodone | 22 | $892 | $41 |
| Hydrocodone-Acetaminophen | 30 | $883 | $29 |
| Pregabalin | 13 | $847 | $65 |
| Bupropion Xl | 14 | $830 | $59 |
| Rosuvastatin | 32 | $829 | $26 |
| Losartan | 78 | $805 | $10 |
| Lisinopril | 105 | $796 | $8 |
| Amlodipine Besylate | 111 | $721 | $6 |
| Ezetimibe | 17 | $719 | $42 |
| Famotidine | 32 | $664 | $21 |
| Venlafaxine Hcl Er | 26 | $625 | $24 |
| Albuterol Sulfate Hfa | 11 | $601 | $55 |
| Fluticasone Propionate | 29 | $578 | $20 |
| Hydrochlorothiazide | 73 | $540 | $7 |
| Chlorthalidone | 12 | $535 | $45 |
| Klor-Con M20 | 15 | $533 | $36 |
| Carvedilol | 58 | $533 | $9 |
| Potassium Chloride | 22 | $515 | $23 |
| Losartan-Hydrochlorothiazide | 14 | $495 | $35 |
| Olmesartan Medoxomil | 11 | $491 | $45 |
| Lansoprazole | 23 | $478 | $21 |
| Sertraline | 42 | $471 | $11 |
| Oxycodone-Acetaminophen | 11 | $469 | $43 |
| Spironolactone | 34 | $428 | $13 |
| Pravastatin | 19 | $419 | $22 |
| Azelastine | 13 | $395 | $30 |
| Nyamyc | 17 | $388 | $23 |
| Metformin | 51 | $384 | $8 |
| Allopurinol | 22 | $362 | $16 |
| Escitalopram | 25 | $351 | $14 |
| Lisinopril-Hydrochlorothiazide | 29 | $300 | $10 |
| Duloxetine | 13 | $233 | $18 |
| Metformin Hcl Er | 27 | $231 | $9 |
| Pantoprazole | 19 | $225 | $12 |
| Glipizide Er | 26 | $221 | $9 |
| Paroxetine | 11 | $208 | $19 |
| Fluoxetine | 24 | $165 | $7 |
| Citalopram Hbr | 23 | $147 | $6 |
| Alprazolam | 18 | $132 | $7 |
| Simvastatin | 14 | $123 | $9 |
| Triamterene-Hydrochlorothiazid | 11 | $117 | $11 |
| Tramadol | 13 | $113 | $9 |
| Cyclobenzaprine | 12 | $110 | $9 |
| Clopidogrel | 11 | $107 | $10 |
| Hydralazine | 13 | $106 | $8 |
| Nystatin | 12 | $106 | $9 |
| Montelukast | 12 | $105 | $9 |
| Furosemide | 23 | $89 | $4 |
| Triamcinolone Acetonide | 11 | $75 | $7 |
2019: 22 drugs
| Trazodone | 12 | $612 | $51 |
| Atorvastatin | 51 | $552 | $11 |
| Levothyroxine | 22 | $491 | $22 |
| Venlafaxine Hcl Er | 16 | $477 | $30 |
| Diclofenac | 12 | $462 | $38 |
| Lisinopril | 39 | $358 | $9 |
| Gabapentin | 25 | $349 | $14 |
| Nyamyc | 11 | $349 | $32 |
| Metformin | 30 | $284 | $9 |
| Ranitidine | 16 | $238 | $15 |
| Omeprazole | 13 | $205 | $16 |
| Metoprolol | 15 | $176 | $12 |
| Amlodipine Besylate | 17 | $162 | $10 |
| Hydrochlorothiazide | 29 | $155 | $5 |
| Sertraline | 33 | $151 | $5 |
| Glipizide Er | 13 | $132 | $10 |
| Carvedilol | 15 | $128 | $9 |
| Allopurinol | 15 | $122 | $8 |
| Escitalopram | 16 | $85 | $5 |
| Lisinopril-Hydrochlorothiazide | 12 | $78 | $6 |
| Losartan | 11 | $63 | $6 |
| Prednisone | 13 | $42 | $3 |
Professional record
- NPI
- 1700838877
- Licence
- CA 63902California A63902: Cancelled
- Trained
- New York Medical College, 1996 · 30 years ago
- Group
- Legacy Healthcare Services Inc · Duke Health Integrated Practice Inc · Duke University Affiliated Physicians, Inc.
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 1265 Welch Rd, Medical School Office Building Rm X3c46, Stanford, CA, 94305
- NPI first listed
- 2006-05-17
- NPI last updated
- 2016-03-16
This is when the NPI record was last certified, not a medical board exam.